Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Ironwood Pharmaceuticals, Inc. (IRWD) had Return on Equity of 11.19% for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$41.14M |
|
$-37.39M |
|
-- |
|
$41.14M |
|
$70.25M |
|
$-29.11M |
|
$-7.16M |
|
$-36.27M |
|
$-36.27M |
|
$-37.39M |
|
$-37.39M |
|
$-37.39M |
|
$-37.39M |
|
$-29.11M |
|
$-28.63M |
|
160.97M |
|
160.97M |
|
$-0.23 |
|
$-0.23 |
|
| Balance Sheet Financials | |
$160.58M |
|
$4.26M |
|
$166.63M |
|
$327.21M |
|
$48.10M |
|
$584.16M |
|
$613.17M |
|
$661.27M |
|
$-334.05M |
|
$-336.71M |
|
$-334.05M |
|
161.81M |
|
| Cash Flow Statement Financials | |
$19.95M |
|
$-0.03M |
|
$0.01M |
|
$88.56M |
|
$108.48M |
|
$19.92M |
|
$5.29M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.34 |
|
-- |
|
-- |
|
2.34 |
|
-1.75 |
|
100.00% |
|
-70.75% |
|
-70.75% |
|
-- |
|
-88.16% |
|
-90.87% |
|
$19.92M |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
-- |
|
1.03 |
|
86.99 |
|
|
Return on Equity |
11.19% |
11.10% |
|
-11.43% |
|
-14.95% |
|
$-2.06 |
|
$0.12 |
|
$0.12 |
|